Pharmacogenomics logo Future Medicine logo

Pharmacogenomics provides the community with an essential resource for keeping abreast of the latest developments in new pharmacogenomic initiatives, emerging technologies for accessing genomic information and the development of novel diagnostic products and strategies.

Publisher: Future Medicine

Volume 7, Number 5, July 2006
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Bulletin Board

Joint pharmacogenomic data submissions guidance released by the US FDA, European Commission and the European Medicines Agency
pp. 659-661(3)

Research Report

Gene signature of breast cancer cell lines treated with lycopene
pp. 663-672(10)
Authors: Chalabi, Nasséra; Delort, Laëtitia; Le Corre, Ludovic; Satih, Samir; Bignon, Yves-Jean; Bernard-Gallon, Dominique

Arylamine N-acetyltransferase gene polymorphisms: markers for atopic asthma, serum IgE and blood eosinophil counts
pp. 673-682(10)
Authors: Batra, Jyotsna; Sharma, Surendra K; Ghosh, Balaram

IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy
pp. 683-695(13)
Authors: Tolusso, Barbara; Pietrapertosa, Donatello; Morelli, Alessia; De Santis, Maria; Gremese, Elisa; Farina, Giuseppina; Carniello, Siro Giorgio; Del Frate, Marino; Ferraccioli, Gianfranco

Genetic predisposition of responsiveness to therapy for chronic hepatitis C
pp. 697-709(13)
Authors: Hwang, Yuchi; Chen, Ellson Y; Gu, Z John; Chuang, Wan-Long; Yu, Ming-Lung; Lai, Ming-Yang; Chao, You-Chen; Lee, Chuan-Mo; Wang, Jing-Houng; Dai, Chia-Yen; Shian-Jy Bey, Monica; Liao, Ya-Tang; Chen, Pei-Jer; Chen, Ding-Shinn

Glutathione S-transferases μ1, θ1, π1, α1 and μ3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans
pp. 711-718(8)
Authors: Martínez, Carmen; Martín, Felipe; Fernández, Juana M; García-Martín, Elena; Sastre, Javier; Díaz-Rubio, Manuel; Agúndez, José AG; Ladero, José M

Review

Pharmacogenetics of alkylator-associated acute myeloid leukemia
pp. 719-729(11)
Authors: Knoche, Eric; McLeod, Howard L; Graubert, Timothy A

Genetic association studies in epilepsy pharmacogenomics: lessons learnt and potential applications
pp. 731-745(15)
Authors: Depondt, Chantal; Shorvon, Simon D

Epigenetics: an emerging technology in the diagnosis and treatment of cancer
pp. 747-757(11)
Authors: Stebbing, Justin; Bower, Mark; Syed, Nelofer; Smith, Paul; Yu, Veronica; Crook, Tim

The application of CD antigen proteomics to pharmacogenomics
pp. 759-771(13)
Authors: Woolfson, Adrian; Ellmark, Peter; Chrisp, Jeremy S; A Scott, Mike; Christopherson, Richard I

Perspective

Process map proposal for the validation of genomic biomarkers
pp. 773-782(10)
Authors: Goodsaid, Federico; Frueh, Felix

Special Report

Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe
pp. 783-792(10)
Authors: van den Akker-van Marle, M Elske; Gurwitz, David; Detmar, Symone B; Enzing, Christine M; Hopkins, Michael M; Gutierrez de Mesa, Emma; Ibarreta, Dolores

Company Profile

Gene Express Inc
pp. 793-796(4)
Author: Saccomanno, Colette F

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A